Mapi USA

Mapi is a premier global contract research organization (CRO) specializing in patient-centered health outcomes and real-world evidence. The company provides a comprehensive suite of services including Health Economics and Outcomes Research (HEOR), market access strategy, and regulatory consulting. Mapi is widely recognized for its industry-leading expertise in Patient-Reported Outcomes (PRO) and its management of the Mapi Research Trust, a significant repository for clinical outcome assessments. Following its acquisition by ICON plc in 2017, Mapi's capabilities were integrated to enhance ICON's late-phase research and commercialization offerings. The organization serves a diverse range of pharmaceutical, biotech, and medical device clients globally to demonstrate the value of their therapeutic products.